Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074997
Status:
COMPLETED
Last Update Posted:
2016-06-20
First Post:
2003-12-28
Brief Title:
An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 CD34 Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 HIV-1 Ribozyme OZ1 in Participants With HIV-1 Infection
Sponsor:
Janssen-Cilag Pty Ltd
Organization:
Janssen-Cilag Pty Ltd
Organization Data
Organization:
Janssen-Cilag Pty Ltd
Class:
INDUSTRY
Study ID:
CR010783
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen-Cilag Pty Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None